Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

13.80
Delayed Data
As of 10:21am ET
 -0.12 / -0.86%
Today’s Change
9.58
Today|||52-Week Range
30.41
-38.01%
Year-to-Date

Today’s Trading

Previous close13.92
Today’s open13.97
Day’s range13.65 - 14.03
Volume101,284
Average volume (3 months)455,302
Market cap$313.9M
Dividend yield--
Data as of 10:21am ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-1.80%
Earnings growth (this year)-48.83%
Earnings growth (next 5 years)-5.76%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...-0.03-0.61%
AQXPAquinox Pharmaceutic...-0.22-1.53%
PRTKParatek Pharmaceutic...-0.13-0.93%
IDRAIdera Pharmaceutical...-0.08-3.20%
Data as of 10:36am ET, 09/29/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$0.00
Annual profit (last year)-$49.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

Search for Jobs